Reaction

Lumbar Spinal Stenosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,894 reports · 175 co-occurring drugs

As of the last recalculation, Lumbar Spinal Stenosis appears in 2,894 FAERS reports alongside 175 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 40.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Alendronate Sodium	476	40.4	40.6
Chlorhexidine Gluconate	25	19.8	19.9
Raloxifene Hydrochloride	31	15.4	15.5
Risedronate Sodium	60	14.2	14.2
Vitamin E	55	12.8	12.8
Carisoprodol	32	12.2	12.2
Cimetidine	16	12.0	12.0
Ascorbic Acid	37	11.6	11.6
Prochlorperazine Maleate	14	11.0	11.0
Quinine	13	10.9	11.0
Docusate Sodium - Sennosides	48	10.9	10.9
Methylprednisolone Acetate	12	10.8	10.8
Methocarbamol	32	10.2	10.3
Meclizine Hcl 12.5Mg	19	10.1	10.1
Meclizine Hcl 25Mg	19	10.1	10.1
Meclizine Hcl 12.5 Mg	19	10.1	10.1
Meclizine Hcl 25 Mg	19	10.1	10.1
Tizanidine Hydrochloride	25	10.0	10.0
Standardized Senna Concentrate	17	9.8	9.8
Liothyronine Sodium	11	9.1	9.1
Emtricitabine And Tenofovir Alafenamide	14	8.9	8.9
Meclizine	20	8.9	8.9
Tolterodine Tartrate	11	8.8	8.9
Tizanidine	29	8.8	8.8
Meperidine Hydrochloride	11	8.6	8.6
Magnesium Hydroxide	16	8.6	8.6
Clobetasol Propionate Ointment Usp, 0.05%	12	8.4	8.4
Clobetasol Propionate	12	8.4	8.4
Meclizine Hydrochloride	22	8.1	8.1
Losartan Potassium And Hydrochlorothiazide	13	8.1	8.1
Bicalutamide	17	8.1	8.1
Docusate Sodium	63	8.0	8.0
Clindamycin	31	7.9	7.9
Clindamycin Phosphate	36	7.8	7.8
Primidone	11	7.8	7.8
Baricitinib	10	7.5	7.5
Diphenoxylate Hydrochloride And Atropine Sulfate	14	7.4	7.4
Tafamidis	12	7.4	7.4
Pravastatin Sodium	20	7.3	7.3
Celecoxib	128	7.3	7.3
Glyburide	24	7.2	7.2
Ketoconazole	17	7.1	7.1
Lovastatin	25	7.1	7.1
Conjugated Estrogens	56	7.0	7.0
Estrogens, Conjugated	57	7.0	7.0
Goserelin	13	7.0	7.0
Meloxicam	55	6.9	6.9
Lidocaine, Menthol	47	6.9	6.9
Lidicaine	46	6.9	6.9
Burn Relief	46	6.9	6.9
Lidocaine Hydrochloride And Epinephrine	46	6.8	6.8
Ketoconazole Foam	14	6.8	6.8
Ketoconazole Cream, 2%	14	6.8	6.8
Diltiazem Hydrochloride	32	6.7	6.7
Bisacodyl Suppositories	12	6.7	6.7
Polyethylene Glycol	10	6.7	6.7
Gemfibrozil	14	6.7	6.7
Biscodyl	12	6.6	6.6
Cyanocobalamin	30	6.6	6.6
Psyllium Husk	9	6.6	6.6
Lidocaine Hydrochloride And Epinephrine Bitartrate	48	6.6	6.6
Temazepam	34	6.6	6.6
Lidocaine Hydrochloride	54	6.5	6.6
Methocarbamol Tablets	15	6.5	6.5
Enalapril Maleate	22	6.4	6.4
Metolazone	10	6.4	6.4
Rabeprazole Sodium	24	6.4	6.4
Cephalexin	19	6.3	6.4
Loratadine And Pseudoephedrine Sulfate	7	6.3	6.3
Cefazolin	8	6.3	6.3
Lidocaine 4%	47	6.3	6.3
Zolpidem Tartrate	114	6.3	6.3
Fexofenadine Hcl	8	6.2	6.2
Dutasteride	7	6.2	6.2
Ezetimibe And Simvastatin	13	6.2	6.2
Bisacodyl	12	6.2	6.2
Lidocaine	49	6.1	6.1
Oxycodone Hydrochloride And Acetaminophen	82	6.1	6.1
Desloratadine	9	6.1	6.1
Ketoprofen	11	6.0	6.1
Biotin	26	6.0	6.0
Cefazolin Sodium	10	6.0	6.0
Thalidomide	30	5.9	5.9
Diclofenac Sodium 1%	29	5.9	5.9
Diclofenac Sodium Topical	29	5.9	5.9
Diclofenac Sodium Topical Gel, 1%	29	5.9	5.9
Sennosides 8.6 Mg Tablets	17	5.9	5.9
Romosozumab-Aqqg	11	5.8	5.9
Rasagiline Mesylate	9	5.8	5.8
Senna	17	5.8	5.8
Timolol Maleate	8	5.8	5.8
Calcium	114	5.7	5.7
Senna Leaf	18	5.6	5.6
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	7	5.6	5.6
Ibuprofen And Diphenhydramine Citrate	18	5.6	5.6
Niacin	9	5.6	5.6
Magnesium Oxide	32	5.6	5.6
Gabapentin	259	5.5	5.5
Prochlorperazine	21	5.5	5.5
Modafinil	24	5.4	5.4
Baclofen	63	5.4	5.4
Fondaparinux Sodium	6	5.3	5.3
Lubiprostone	7	5.3	5.3
Anastrozole	27	5.3	5.3
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	13	5.2	5.2
Letrozole	43	5.1	5.1
Exemestane	15	5.1	5.1
Upadacitinib	56	5.0	5.0
Salmeterol Xinafoate	6	5.0	5.0
Guaifenesin	21	5.0	5.0
Esomeprazole Magnesium	155	5.0	5.0
Testosterone	16	4.9	4.9
Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hcl	34	4.9	4.9
Pitavastatin Calcium	7	4.9	4.9
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	14	4.9	4.9
Naproxen Sodium, Pseudoephedrine Hydrochloride	14	4.9	4.9
Zoledronic Acid	27	4.9	4.9
Dolutegravir Sodium	6	4.8	4.8
Bupropion Hydrochloride	64	4.7	4.7
Pregabalin	169	4.7	4.7
Conjugated Estrogens And Medroxyprogesterone Acetate	15	4.6	4.6
Erythropoietin	13	4.6	4.6
Quinapril Hydrochloride	5	4.6	4.6
Duloxetine Hydrochloride	115	4.5	4.5
Crisaborole	6	4.5	4.5
Vibegron	5	4.5	4.5
Loratadine Tablet	33	4.5	4.5
Tofacitinib Citrate	8	4.4	4.4
Interferon Beta-1A	112	4.3	4.3
Darbepoetin Alfa	31	4.2	4.2
Granisetron Hydrochloride	6	4.1	4.1
Oxycodone And Acetaminophen	13	4.0	4.0
Eszopiclone	14	4.0	4.0
Donepezil Hydrochloride	20	3.9	3.9
Teriparatide	59	3.8	3.8
Fluticasone Propionate And Salmeterol	22	3.8	3.8
Armodafinil	11	3.8	3.8
Tenofovir Disoproxil Fumarate	17	3.7	3.7
Memantine	7	3.7	3.7
Memantine Hydrochloride	7	3.7	3.7
Oxycodone	93	3.7	3.7
Dorzolamide Hydrochloride And Timolol Maleate	4	3.6	3.6
Hydromorphone Hydrochloride	45	3.6	3.6
Ziprasidone Mesylate	7	3.5	3.5
Carbidopa And Levodopa	23	3.5	3.5
Emtricitabine And Tenofovir Disoproxil Fumarate	22	3.5	3.5
Granisetron	5	3.4	3.4
Cannabidiol	11	3.4	3.4
Denosumab	92	3.3	3.3
Fesoterodine Fumarate	5	3.3	3.3
Fentanyl Citrate	8	3.2	3.2
Ravulizumab	6	3.2	3.2
Hydrocodone Bitartrate And Acetaminophen	24	3.1	3.1
Dalfampridine	30	3.0	3.0
Sodium Oxybate	27	3.0	3.0
Morphine Sulfate	49	2.9	2.9
Medroxyprogesterone Acetate	20	2.9	2.9
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	4	2.9	2.9
Prasugrel Hydrochloride	4	2.8	2.8
Dronedarone	4	2.8	2.8
Suvorexant	5	2.8	2.8
Oxycodone Hydrochloride	82	2.8	2.8
Golimumab	32	2.7	2.7
Bortezomib	33	2.7	2.7
Abatacept	49	2.6	2.6
Ixazomib	10	2.5	2.5
Alteplase	5	2.4	2.4
Cortisone Acetate	4	2.3	2.3
Peginterferon Beta-1A	4	2.2	2.2
Natalizumab	52	2.1	2.1
Paricalcitol	4	2.0	2.0
Methoxy Polyethylene Glycol-Epoetin Beta	3	2.0	2.0
Exenatide	13	1.8	1.8
Onabotulinumtoxina	18	1.7	1.7
Hydrocodone Bitartrate	8	1.3	1.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.